Filter your results
- 3
- 1
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction modeEuropean Journal of Medicinal Chemistry, 2018, 159, pp.357-380. ⟨10.1016/j.ejmech.2018.10.003⟩
Journal articles
inserm-01980723v1
|
||
Binding mode of Pyridoclax to Myeloid cell leukemia-1 (Mcl-1) revealed by Nuclear Magnetic Resonance Spectroscopy, Docking and Molecular Dynamics ApproachesJournal of Biomolecular Structure and Dynamics, 2019, (in press). ⟨10.1080/07391102.2019.1680434⟩
Journal articles
hal-02330946v1
|
|||
|
Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.Drug Design, Development and Therapy, 2021, 15, pp.5035-5059. ⟨10.2147/dddt.s323077⟩
Journal articles
hal-03576776v1
|
||
An innovative chemometric method for processing direct introduction high resolution mass spectrometry metabolomic data: independent component–discriminant analysis (IC–DA)Metabolomics, 2017, 13 (4), pp.1-12. ⟨10.1007/s11306-017-1179-x⟩
Journal articles
hal-01665227v1
|